logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Diabetes Mellitus Noninsulindependent

    Medications for Diabetes Mellitus Noninsulindependent

    FiltersReset Filters
    52 results

    • acarbose

      (acarbose)
      Chartwell RX, LLC
      Usage: Acarbose tablets are indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus.

    • atorvastatin calcium

      (Atorvastatin calcium)
      NIVAGEN PHARMACEUTICALS, INC.
      Usage: Atorvastatin calcium is indicated to reduce the risk of myocardial infarction, stroke, and angina in at-risk adults. It also lowers LDL cholesterol in adults with hyperlipidemia, heterozygous or homozygous familial hypercholesterolemia, and treats primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.

    • basaglar

      (Insulin glargine)
      Eli Lilly and Company
      Usage: BASAGLAR® is indicated for improving glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.

    • brenzavvy

      (Bexagliflozin)
      TheracosBio, LLC
      Usage: BRENZAVVY is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes mellitus.

    • colesevelam hydrochloride

      (COLESEVELAM HYDROCHLORIDE)
      Amneal Pharmaceuticals of New York LLC
      Usage: Colesevelam hydrochloride tablets are indicated to reduce elevated LDL cholesterol in adults with primary hyperlipidemia and in boys/girls (10-17 years) with heterozygous familial hypercholesterolemia. Additionally, it is used to improve glycemic control in adults with type 2 diabetes mellitus, alongside diet and exercise.

    • colesevelam hydrochloride

      (colesevelam hydrochloride)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Colesevelam hydrochloride tablets are indicated to reduce elevated LDL cholesterol in adults with primary hyperlipidemia and in boys/postmenarchal girls aged 10-17 with heterozygous familial hypercholesterolemia. Additionally, they improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise.

    • colesevelam hydrochloride

      (Colesevelam Hydrochloride)
      Glenmark Pharmaceuticals Inc.,USA
      Usage: Colesevelam hydrochloride is indicated as an adjunct to diet and exercise for reducing LDL cholesterol in adults with primary hyperlipidemia and in boys/girls aged 10-17 with heterozygous familial hypercholesterolemia. It also improves glycemic control in adults with type 2 diabetes mellitus. Not for type 1 diabetes or diabetic ketoacidosis.

    • cycloset

      (bromocriptine mesylate)
      Avvisto Therapeutics LLC
      Usage: CYCLOSET is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not for type 1 diabetes or diabetic ketoacidosis, and its efficacy is limited when used with thiazolidinediones or insulin.

    • farxiga

      (DAPAGLIFLOZIN)
      AstraZeneca Pharmaceuticals LP
      Usage: FARXIGA (dapagliflozin) is indicated for reducing risks associated with chronic kidney disease, heart failure, and for improving glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, alongside diet and exercise. It is not recommended for type 1 diabetes or specific kidney conditions.

    • glimepiride

      (Glimepiride)
      Rising Pharma Holdings, Inc.
      Usage: Glimepiride tablets are indicated to improve glycemic control in adults with type 2 diabetes mellitus, used alongside diet and exercise. They are not intended for type 1 diabetes or diabetic ketoacidosis treatment.